0001127602-21-023776.txt : 20210816
0001127602-21-023776.hdr.sgml : 20210816
20210816161535
ACCESSION NUMBER: 0001127602-21-023776
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210816
DATE AS OF CHANGE: 20210816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nikel Chad M.
CENTRAL INDEX KEY: 0001877325
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 211178376
MAIL ADDRESS:
STREET 1: C/O HAEMONETICS CORPORATION
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0402
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2021-08-06
0
0000313143
HAEMONETICS CORP
HAE
0001877325
Nikel Chad M.
125 SUMMER STREET
BOSTON
MA
02110
1
President, Global Plasma & BC
Common Stock
17336
D
Non-qualified Stock Option (Right to Buy)
56.57
2028-05-18
Common Stock
8966
D
Non-qualified Stock Option (Right to Buy)
103.37
2027-05-18
Common Stock
5319
D
Non-qualified Stock Option (Right to Buy)
98.025
2026-05-14
Common Stock
5342
D
Non-qualified Stock Option (Right to Buy)
93.52
2025-06-11
Common Stock
4282
D
Non-qualified Stock Option (Right to Buy)
41.64
2024-06-06
Common Stock
1968
D
12,187 securities are in the form of unvested restricted stock units ("RSUs") issued pursuant to the Issuer's 2005 Long-Term Incentive Compensation Plan (as amended) or 2019 Long-Term Incentive Compensation Plan. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. 5,559 of such RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant, with shares vesting on various dates between May 2022 and May 2025. 6,628 of such RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant, with shares vesting in May 2022 and May 2023.
Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on May 18, 2020 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on May 14, 2019 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on June 11, 2018 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on June 6, 2017 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Nikel
2021-08-16